| 21-06-25 | NattoPharma ASA : - Delisting | AQ |
| 21-06-15 | NattoPharma : Received application for delisting | AQ |
| 21-06-14 | NattoPharma : Annual General Meeting in NattoPharma ASA | AQ |
| 21-06-10 | NattoPharma : OSLO BØRS - SUSPENDED | AQ |
| 21-06-09 | NattoPharma ASA: Compagnie des Levures Lesaffre announces compulsory acquisition | AQ |
| 1 day | +2.35% |
| Manager | Title | Age | Since |
|---|---|---|---|
Kjetil Ramsøy
CEO | Chief Executive Officer | 54 | 2018-02-07 |
Robert Schrama
DFI | Director of Finance/CFO | - | 2020-03-08 |
Gunilla Traberg
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Frode Marc Bohan
CHM | Chairman | 58 | 2004-11-03 |
| Director/Board Member | 52 | 2011-01-31 | |
Kjetil Ramsøy
BRD | Director/Board Member | 54 | 2015-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.35% | +1.46% | - | - | 86.2M | |
| +0.28% | -5.97% | +58.34% | +108.22% | 1,031B | |
| +2.01% | -0.71% | +53.07% | +68.99% | 641B | |
| +1.39% | -2.18% | +23.57% | +75.43% | 453B | |
| -1.50% | -7.04% | +33.55% | +33.94% | 349B | |
| +6.25% | +2.04% | +28.97% | +46.57% | 290B | |
| -0.07% | -4.12% | +0.95% | +11.79% | 252B | |
| +1.92% | -0.93% | +52.28% | +70.67% | 232B | |
| +0.51% | -4.52% | -19.50% | -54.83% | 201B | |
| +2.45% | +0.77% | +32.71% | +95.59% | 181B | |
| Average | +1.69% | -2.91% | +29.33% | +50.71% | 403.31B | |
| Weighted average by Cap. | +1.60% | -3.40% | +38.39% | +66.40% |
Employees
18
Sector
Pharmaceuticals
